Birchbrook’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$911K Sell
3,586
-1,353
-27% -$315K 0.43% 40
2026
Q1
$1.21M Sell
4,939
-58
-1% -$13.5K 0.59% 35
2025
Q4
$1.03M Buy
4,997
+58
+1% +$11.5K 0.52% 37
2025
Q3
$916K Sell
4,939
-55
-1% -$9.42K 0.47% 39
2025
Q2
$763K Sell
4,994
-30
-0.6% -$4.61K 0.41% 43
2025
Q1
$833K Sell
5,024
-375
-7% -$58.7K 0.47% 40
2024
Q4
$781K Buy
5,399
+200
+4% +$31K 0.44% 42
2024
Q3
$843K Hold
5,199
0.47% 42
2024
Q2
$760K Sell
5,199
-5
-0.1% -$744 0.46% 39
2024
Q1
$823K Sell
5,204
-5
-0.1% -$796 0.49% 39
2023
Q4
$817K Buy
+5,209
New +$799K 0.54% 42

Other funds holding JNJ

Birchbrook's JNJ Position: Q2 2026 in Review

Birchbrook reduced its Johnson & Johnson (JNJ) stake by 27% in Q2 2026, selling an estimated $315K and leaving 3,586 shares worth $911K. The position accounts for 0.43% of the portfolio, ranked #40.

Birchbrook first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.21M in Q1 2026. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Birchbrook held 3,586 shares of Johnson & Johnson worth $911K as of Q2 2026.
  • Birchbrook sold 1,353 Johnson & Johnson shares in Q2 2026, an estimated $315K.
  • Johnson & Johnson made up 0.43% of Birchbrook's portfolio in Q2 2026, its #40 holding.
  • Birchbrook first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Birchbrook's Johnson & Johnson position peaked at $1.21M in Q1 2026.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Birchbrook's 13F filing for Q2 2026, filed 9 Jul 2026.